期刊文献+

厄贝沙坦氢氯噻嗪片工艺验证

Technology Verification for Irbesartan and Hydrochlorothiazide Tablets
下载PDF
导出
摘要 目的:验证厄贝沙坦氢氯噻嗪片中试工艺的可行性、可靠性。方法:按照确定的处方工艺中试生产3批样品,对工艺中的关键工艺参数进行验证。结果:验证批次的厄贝沙坦氢氯噻嗪片各项指标符合质量标准要求。结论:厄贝沙坦氢氯噻嗪片中试工艺生产可行,工艺流程及工艺参数能够保证产品质量;工艺可靠、稳定。 Objective: To verify the feasibility and reliability of the pilot process of irbesartan and hydrochlorothiazide tablets. Methods:Three batches of the tablets were produced according to the determined formula and process, and the key parameters in the pilot production were verified. Results:All the indices for each batch of irbesartan and hydrochlorothiazide tablets conformed to the re-quirements of the quality standard. Conclusion: The pilot process of irbesartan and hydrochlorothiazide tablets is feasible, and the technological process and parameters can ensure the product quality with promising reliability and stability.
作者 陈晓梅
出处 《中国药师》 CAS 2015年第3期490-493,共4页 China Pharmacist
关键词 厄贝沙坦氢氯噻嗪片 工艺参数 验证 Irbesartan and hydrochlorothiazide tablets Process parameter Verification
  • 相关文献

参考文献4

二级参考文献13

  • 1丁一冰,樊夏雷,沈建平,王训强.Cap-HPLC测定人血浆中厄贝沙坦和氢氯噻嗪浓度及其复方制剂的生物等效性研究[J].中国药科大学学报,2005,36(6):551-555. 被引量:17
  • 2孙启泉,刘燕,施介华,王荣.RP-HPLC法测定厄贝沙坦的含量及有关物质[J].浙江化工,2006,37(6):28-29. 被引量:10
  • 3王鹏,袁丽霞,吴永芹,王乃东.HPLC法测定复方罗布麻片(Ⅱ)中氢氯噻嗪的含量[J].中国药事,2007,21(5):332-333. 被引量:1
  • 4FDA. Guidance for Industry Process Validation: General Principles and Practices[EB/OL3. [2011-01-24]. http://www. fda.gov/ ion/Guidances/UCM070336.pdf.
  • 5中华人民共和国卫生部.药品生产质量管理规范[EB/OL].[2011-02—12].http://www.sfda.gov.cn/WS01/CL0053/58500.html.
  • 6EMEA. Note for Guidance on Process Validation [EB/ OL]. [ 2001-03-01 ]. http://www.ema.europa.eu/docs/ en_GB/documentjibrary/Scientific guideline/2009/09/ WC500002913.pdf.
  • 7WHO. Validation: Annex 4, Supplementary Guidelines on Good Manufacturing Practices: Validation [EB/OL]. [2006-01-12]. http://www.who,int/medicines/publications/pharmprep/TRS 937.pdf#page= 119.
  • 8EMEA. Guideline on the Limits of Genotoxic Impurities EEB/OLJ. 2006-06-283. http://www.ema.europa.eu/docs/ en_GB/document library/Scientific_guideline/2009/09/ WC500002903.pdf.
  • 9国家食品药品监督管理局药品审评中心.化学药物原料药制备和结构确证研究技术指导原则[EB/OL].[2007—08-23].http://www.cde.org.cn/zdyz.do?method.largePage&id=2067.
  • 10ICH. Pharmaceutical Development Q8(R2) EB/ OL. [2009-08-12]. http://www.ich.org/fileadmin/ Public Web_Site/ICH_Products/Guidelines/Quality/Q8_R1/ Step4/Q8 R2_Guideline.pdf.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部